HomePressAbout UsContact UsMy Account

• Patients

  

  Understanding EarlyCDT^™

  EarlyCDT^™ uses a highly reliable technology of testing to identify early-stage cancer. Learn More >

  EarlyCDT^™—Lung Brochure

  Our informative booklet of the features and benefits of EarlyCDT^™ for Lung cancer. Download >

  Is this test right for me now?

  Calculate now >

• Providers

  

  Who Benefits from EarlyCDT^™

  EarlyCDT^™ gives the advantage of earlier detection to patients at increased risk of developing certain cancers. Learn More >

  Technology

  Autoantibodies specific to cancer-related antigens are key to an early detection success. Learn More >

  New peer review article now available at Annals of Oncology. Learn More >

  What is the 5-year risk?

  Learn More >

  Join our Webcast

  to share in results to date.

  Check dates and times >

• Investors

  

  The Future of EarlyCDT^™

  Ongoing research holds great promise for an expanding line of EarlyCDT^™ products. Learn More >

• Research Partners

  

  Understanding EarlyCDT^™

  Oncimmune has attracted the interest and participation of leading cancer researchers. Learn More >